SEER 📈 Seer - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US81578P1066

SEER: Nanoparticles, Consumables, Automation, Instrumentation, Software

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Web URL: https://seer.bio

Additional Sources for SEER Stock

SEER Stock Overview

Market Cap in USD 147m
Sector Healthcare
Industry Biotechnology
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception 2020-12-04

SEER Stock Ratings

Growth 5y -74.8%
Fundamental -44.8%
Dividend -
Rel. Strength Industry 1139
Analysts 3.67/5
Fair Price Momentum 1.59 USD
Fair Price DCF -

SEER Dividends

No Dividends Paid

SEER Growth Ratios

Growth Correlation 3m 83.9%
Growth Correlation 12m 37.4%
Growth Correlation 5y -95.1%
CAGR 5y -54.53%
CAGR/Mean DD 5y -0.66
Sharpe Ratio 12m 0.63
Alpha -29.32
Beta 2.41
Volatility 46.42%
Current Volume 218.7k
Average Volume 20d 212.2k
What is the price of SEER stocks?
As of December 21, 2024, the stock is trading at USD 2.31 with a total of 218,668 shares traded.
Over the past week, the price has changed by -5.69%, over one month by +1.75%, over three months by +31.82% and over the past year by +28.89%.
Is Seer a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Seer (NASDAQ:SEER) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.78 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SEER as of December 2024 is 1.59. This means that SEER is currently overvalued and has a potential downside of -31.17%.
Is SEER a buy, sell or hold?
Seer has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold SEER.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SEER stock price target?
According to ValueRays Forecast Model, SEER Seer will be worth about 1.8 in December 2025. The stock is currently trading at 2.31. This means that the stock has a potential downside of -21.21%.
Issuer Forecast Upside
Wallstreet Target Price 3 29.9%
Analysts Target Price 7.5 224.7%
ValueRay Target Price 1.8 -21.2%